Narrow search
Showing 1 - 10 of 517,212
Cover Image
Advertising, competition, and regulation in the pharmaceutical industry
Suppliet, Moritz - 2016
Persistent link: https://www.econbiz.de/10011459973
Cover Image
The diffusion of generics after patent expiry in Germany
Blankart, Katharina; Stargardt, Tom - In: The European journal of health economics : HEPAC ; … 17 (2016) 8, pp. 1027-1040
Persistent link: https://www.econbiz.de/10011660160
Cover Image
Direktverträge mit den Krankenkassen: die Position der pharmazeutischen Industrie
Köbele, Walter - In: Wettbewerb im Gesundheitswesen: Chancen und Grenzen : …, (pp. 175-182). 2008
Persistent link: https://www.econbiz.de/10003807656
Cover Image
Regulation of Pharmaceutical Markets in Germany : Improving Efficiency and Controlling Expenditures?
Busse, Reinhard; Schreyoegg, Jonas; Henke, Klaus-Dirk - 2010
Rising pharmaceutical expenditure has become a major concern for policy makers in Germany over recent years. Therefore …, the pharmaceutical market has been increasingly targeted by different kinds of regulation, focussing on both the supply …
Persistent link: https://www.econbiz.de/10014196884
Cover Image
Gefahren für Innovationen im Arzneimittelbereich: eine ordnungspolitische Analyse
Oberender, Peter; Rüter, Georg - 1988 - 1. Aufl.
Persistent link: https://www.econbiz.de/10000741455
Cover Image
Should product-specific advertisement be regulated in pharmaceutical markets?
Ishida, Junichiro; Takahara, Tsuyoshi - In: Journal of public economic theory 26 (2024) 2, pp. 1-37
Persistent link: https://www.econbiz.de/10014507649
Cover Image
Should product-specific advertisement be regulated in pharmaceutical markets?
Ishida, Junichiro; Takahara, Tsuyoshi - 2022
This paper examines the optimal content regulation of DTCA by comparing two forms of DTCA-product-specific and category …
Persistent link: https://www.econbiz.de/10013329470
Cover Image
Pharmaceutical regulation in Europe and its impact on corporate R&D
Eger, Stephan; Mahlich, Jörg C. - In: Health economics review 4 (2014) 23, pp. 1-9
expenditures. On the other hand, regulation distorts incentives to invest in pharmaceutical R&D. This study aims at empirically … assessing the impact of regulation on pharmaceutical R&D expenditures. Methods: We analyze a sample of 20 leading pharmaceutical … companies between 2000 and 2008. The share of sales in Europe serves as a proxy for the degree of pharmaceutical regulation. We …
Persistent link: https://www.econbiz.de/10010526909
Cover Image
An empirical model of drug detailing : dynamic competition and policy implications
Liu, Qiang; Gupta, Sachin; Venkataraman, Sriram; Liu, Hongju - In: Management science : journal of the Institute for … 62 (2016) 8, pp. 2321-2340
Persistent link: https://www.econbiz.de/10011539516